More articles from Lung Cancer

RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
T-H. Tsai, K-Y. Su, S-G. Wu, Y-L. Chang, S-C. Luo, I-S. Jan, C-J. Yu, S-L. Yu, J-Y. Shih, P-C. Yang

European Respiratory Journal Mar 2012, 39 (3) 677-684; DOI: 10.1183/09031936.00043511
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma
N. Girard, C.S. Sima, D.M. Jackman, L.V. Sequist, H. Chen, J.C-H. Yang, H. Ji, B. Waltman, R. Rosell, M. Taron, M.F. Zakowski, M. Ladanyi, G. Riely, W. Pao

European Respiratory Journal Feb 2012, 39 (2) 366-372; DOI: 10.1183/09031936.00010111
Endobronchial ultrasound-guided lymph node biopsy with transbronchial needle forceps: a pilot study
F.J.F. Herth, H. Schuler, D. Gompelmann, N. Kahn, S. Gasparini, A. Ernst, M. Schuhmann, R. Eberhardt

European Respiratory Journal Feb 2012, 39 (2) 373-377; DOI: 10.1183/09031936.00033311
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3
I. Borget, J. Cadranel, J-P. Pignon, E. Quoix, B. Coudert, V. Westeel, E. Dansin, J. Madelaine, A. Madroszyk, S. Friard, C. Daniel, F. Morin, C. Chouaid, the ERMETIC Collaborative Group

European Respiratory Journal Jan 2012, 39 (1) 172-179; DOI: 10.1183/09031936.00201210

Main menu